Alnylam Pharmaceuticals Inc
ALNY
|
|
| |
|
| Trading Volume | 13,201 |
|
|
287.01 - 144.35 |
| Market Cap Full | $ 36B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -0.4% | -22% | -15.7% | -6.4% |
| Q2 | - | 61.1% | -5.2% | -10.7% |
| Q3 | - | 20.9% | -6.8% | 37.2% |
| Q4 | - | -15.9% | 7% | 18.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.4 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -9.7 | -12.6 | -1.1 | -3.4 | 2.8 | 66.7 | -3.9 | 20.9 | - | - | - | -7 |
| 2023 | |||||||||||
| -4.7 | -15.4 | 4.6 | -0.6 | -7.1 | 2.7 | 2.9 | 1.2 | -10.5 | -14.3 | 10.8 | 13.8 |
| 2022 | |||||||||||
| -21.1 | 12.7 | 5.4 | -13.2 | -11.3 | 15.9 | -3.8 | 47.3 | -3.2 | 3.6 | 6.4 | 7.7 |
| 2021 | |||||||||||
| 16.9 | -2.5 | -4.7 | -0.4 | 1 | 19.4 | 5.6 | 12.6 | -8.3 | -13.7 | 15.2 | -5.1 |
| 2020 | |||||||||||
| -1.3 | -0.8 | -4.3 | 21 | 2.7 | 9.5 | -1.6 | -7.8 | 8.3 | -17.4 | 8.9 | -0.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -1.4 | -2 | -1.7 | -1.6 |
| Q2 | -2.2 | -2.3 | -1.6 | -1.6 |
| Q3 | 1.2 | -3.3 | -1.7 | -2.2 |
| Q4 | 0 | -1.7 | -2.2 | -2.1 |
| A | -2.46 | -9.3 | -7.2 | -7.5 |